Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Mondick

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|March 19, 2013
Model-based drug development applied to oncologyJeffrey S Barrett, Manish Gupta, John T Mondick
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2020
Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progressionJanelle L Lennie, John T Mondick, Marc R Gastonguay
Plos One|April 28, 2022
Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophyJanelle L Lennie, John T Mondick, Marc R Gastonguay
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of ketorolac in neonates and young infantsAthena F Zuppa, John T Mondick, Lisa Davis, et al.
BMC Medical Informatics and Decision Making|January 30, 2008
Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapyJeffrey S Barrett, John T Mondick, Mahesh Narayan, et al.
Clinical and Translational Science|February 11, 2025
Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal SyndromeKevin Lam, John T Mondick, Gary Peltz, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 16, 2013
Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiencyAlisha J Rovner, Joan I Schall, John T Mondick, et al.
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotanJohn T Mondick, Charles Oo, Dimple Patel, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosisVirginia A Stallings, John T Mondick, Joan I Schall, et al.
Journal of Clinical Pharmacology|July 28, 2007
An informatics approach to assess pediatric pharmacotherapy: design and implementation of a hospital drug utilization systemAthena Zuppa, Sundararajan Vijayakumar, Bhuvana Jayaraman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 19, 2013
Model-based drug development applied to oncologyJeffrey S Barrett, Manish Gupta, John T Mondick
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2020
Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progressionJanelle L Lennie, John T Mondick, Marc R Gastonguay
Plos One|April 28, 2022
Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophyJanelle L Lennie, John T Mondick, Marc R Gastonguay
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of ketorolac in neonates and young infantsAthena F Zuppa, John T Mondick, Lisa Davis, et al.
BMC Medical Informatics and Decision Making|January 30, 2008
Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapyJeffrey S Barrett, John T Mondick, Mahesh Narayan, et al.
Clinical and Translational Science|February 11, 2025
Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal SyndromeKevin Lam, John T Mondick, Gary Peltz, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 16, 2013
Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiencyAlisha J Rovner, Joan I Schall, John T Mondick, et al.
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotanJohn T Mondick, Charles Oo, Dimple Patel, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosisVirginia A Stallings, John T Mondick, Joan I Schall, et al.
Journal of Clinical Pharmacology|July 28, 2007
An informatics approach to assess pediatric pharmacotherapy: design and implementation of a hospital drug utilization systemAthena Zuppa, Sundararajan Vijayakumar, Bhuvana Jayaraman, et al.
Pageof 2